Creating vaccines and driving value through partnerships and R&D | Novavax
Novavax is a global biotechnology company with a proven vaccine technology, focused on developing our R&D assets and establishing partnerships to help protect health.
U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine
May 19, 2025 · To report suspected adverse reactions, contact Novavax, Inc. at 1-844-668-2829 or the Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967 or …
Schedule your COVID-19 Vaccine Appointment | Novavax
The Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) has not been approved or licensed by FDA, but has been authorized for emergency use by FDA, under an Emergency …
Novavax's COVID-19 Vaccine: Your Questions Answered
May 20, 2025 · The Novavax vaccine is one of three vaccines available in the U.S. for the prevention of COVID-19 and the only one that does not use the relatively new mRNA vaccine …
Is the Novavax COVID Vaccine Better Than mRNA Vaccines? What …
Oct 16, 2023 · Novavax’s protein-based vaccine is the latest FDA-authorized COVID booster available this fall. Here’s what you should know
Novavax - Wikipedia
Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists …
Novavax COVID-19 Vaccine Summary | Vaccines & Immunizations …
Sep 10, 2024 · Novavax COVID-19 Vaccine, Adjuvanted is indicated for individuals 12 years of age and older. Novavax's product will be presented in prefilled syringes, and there is one …
NUVAXOVID | FDA - U.S. Food and Drug Administration
STN: 125817 Proper Name: COVID-19 Vaccine, Adjuvanted Tradename: NUVAXOVID Manufacturer: Novavax, Inc. Indication: NUVAXOVID is a vaccine indicated for active …
FDA approves Novavax COVID-19 vaccine, but with unusual ... - PBS
May 18, 2025 · Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to grant Novavax full approval – without restrictions …
FDA approves Novavax COVID-19 shot but with unusual restrictions
Novavax makes the nation’s only traditional protein-based coronavirus vaccine – and until now it had emergency authorization from FDA for use in anyone 12 and older. But late Friday, the …